comparemela.com

Latest Breaking News On - Framework programme for research - Page 8 : comparemela.com

Panakès Partners Announces the First Closing Of Its New 'Purple' Global Biotech/ Medtech Fund at €150 Million ($180 Million)

Panakès Partners Announces the First Closing Of Its New 'Purple' Global Biotech/ Medtech Fund at €150 Million ($180 Million)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Fortschritt stärken: Innovationskredit Hessen geht in die Verlängerung

Fortschritt stärken: Innovationskredit Hessen geht in die Verlängerung
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Joint Communiqué on EU-Tunisia relations: 'For a renewed partnership'

Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa

Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa News provided by Share this article Up to 200,000 Johnson & Johnson Ebola vaccine regimens will be made available as part of a WHO early access clinical program now underway in Sierra Leone Company s Ebola vaccine regimen also receives Prequalification from the WHO The Johnson & Johnson vaccine regimen is designed to be used proactively to induce immunity against Ebola in adults and children NEW BRUNSWICK, N.J., May 13, 2021 /PRNewswire/ Johnson & Johnson (NYSE: JNJ) (the Company) today announced the World Health Organization (WHO) and the government of Sierra Leone have begun administering the Company s Ebola vaccine regimen as part of a WHO early access clinical program aimed at preventing further spread of Ebola in West Africa. The vaccine regimen, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) in collaboration with Bavarian Nordic A/S,

Controlled Magneto-Mechanical Processes may Lead to New Generation of Artificial Muscles

Controlled Magneto-Mechanical Processes may Lead to New Generation of Artificial Muscles Written by AZoMMay 7 2021 The overarching idea of this research project is to influence different biological processes at the cellular level (i.e., wound healing, brain synapses or nervous system responses) by developing timely engineering applications , explains 4D-BIOMAP s lead researcher, Daniel García González from the UC3M s Department of Continuum Mechanics and Structural Analysis. The so-called magneto-active polymers are revolutionising the fields of solid mechanics and materials science. These composites consist of a polymeric matrix (i.e., an elastomer) that contains magnetic particles (i.e., iron) that react mechanically by changing their shape and volume.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.